期刊文献+

血管生成素样蛋白3、4在浸润性乳腺癌中的表达及临床意义 被引量:3

Expressions of Angptl 3 and Angptl 4 in invasive breast cancer and clinical significance
原文传递
导出
摘要 目的检测血管生成素样蛋白(angiopoietin-like protein,Angptl)3和Angptl 4在浸润性乳腺癌组织中的表达及其临床意义,为乳腺癌的治疗及预后提供有价值的生物学指标。方法用随机数字表法收集苏北人民医院2007—2009年手术切除浸润性乳腺癌标本70例,乳腺纤维腺瘤标本30例,采用免疫组织化学SP法,检测肿瘤标本中Angptl 3和Angptl 4的表达。采用χ^2检验分析两种蛋白在乳腺癌和乳腺纤维腺瘤中是否具有表达差异性,χ^2检验和Fisher确切概率法分析两种蛋白与乳腺癌临床病理特征之间的关系,Spearman相关分析法分析Angptl 3和Angptl 4两种蛋白在浸润性乳腺癌中表达的相关性,并采用Kaplan-Meier法及Cox比例风险模型进行浸润性乳腺癌患者的生存分析。结果 Angptl 3在浸润性乳腺癌和乳腺纤维腺瘤中的阳性表达率分别为75.7%(53/70)和46.7%(14/30)(χ^2=8.014,P=0.005),Angptl 4在浸润性乳腺癌和乳腺纤维腺瘤中的阳性表达率分别是68.6%(48/70)和36.7%(11/30)(χ^2=8.837,P=0.003),差异均有统计学意义。Angptl 3的表达在不同肿瘤直径、腋窝淋巴结转移、TNM分期、ER表达的患者中差异有统计学意义(χ^2=6.000、5.598、9.714、8.753,P〈0.050)。在70例浸润性乳腺癌中,Angptl 4的表达在不同肿瘤直径、腋窝淋巴结转移、TNM分期的患者中差异有统计学意义(χ^2=8.762、6.526、5.701,P〈0.050)。Angptl 3和Angptl 4表达呈正相关(P=0.005,r=0.334)。Kaplan-Meier分析结果表明,Angptl 3和Angptl 4阴性表达的患者总生存期均优于阳性表达的患者(χ-2=9.376、7.628,P=0.002、0.006)。Cox多因素生存分析结果表明,年龄、组织学分级、肿瘤直径、ER、PR是影响预后的独立危险因素(OR=6.379、0.033、66.678、0.014、0.094,P均〈0.050,95%CI:1.380-29.482、0.002-0.598、5.433-818.294、0.001-0.183、0.012-0.724),Angptl 3和Angptl 4蛋白表达不是影响浸润性乳腺癌患者预后的独立因素(OR=1.262、1.841,P=0.937、0.695,95%CI:0.000-2.281、0.087-39.051)。结论 Angptl 3和Angptl 4在浸润性乳腺癌中高表达,且两者呈正相关。两者阳性表达的患者生存期缩短,但两者均不是影响浸润性乳腺癌患者预后的独立因素。 Objective To detect the expressions of angiopoietin-like proteins(Angptl)3 and Angptl 4in invasive breast cancer and the clinical significance,and explore the potentials as biomarkers for the treatment and prognosis of breast cancer. Methods The tumor samples surgically resected from 70 cases of invasive breast cancer and 30 cases of breast fibroadenoma in Subei People's Hospital from 2007 to 2009 were collected to determine the expressions of Angptl 3 and Angptl 4 with immunohistochemical SP method. χ~2test was used to analyze the expression difference of these two proteins between invasive breast cancer and breast fibroadenoma.χ~2test and Fisher's exact probability method were used to analyze the relationship between the protein expression and clinicopathological characteristics of invasive breast cancer. Spearman correlation analysis was used to detect the correlation between Angptl 3 and Angptl 4 in invasive breast cancer. KaplanMeier method and Cox model were used for survival analysis. Results The positive rate of Angptl 3 was75. 7%(53 / 70)in invasive breast cancer and 46. 7%(14 / 30)in breast fibroadenoma(χ~2= 8. 014,P =0. 005);the positive rate of Angptl 4 was 68. 6%(48 / 70)in invasive breast cancer and 36. 7%(11 / 30)in breast fibroadenoma(χ~2= 8. 837,P = 0. 003),both indicating a significant difference. In 70 cases of invasive breast cancer,Angptl 3 expression showed a significant difference in patients with different tumor size,axillary lymph node metastasis,TNM stage and ER status(χ~2= 6. 000,5. 598,9. 714,8. 753,P 0. 050);Angptl 4expression showed a significant difference in patients with different tumor size,axillary lymph node metastasis and TNM stage(χ~2= 8. 762,6. 526,5. 701,P0. 050);Angptl 3 was positively correlated with Angptl 4(P =0. 005,r = 0. 334). Kaplan-Meier analysis showed that the survival in patient with Angptl 3 / Angptl 4 positive was superior to that in patient with Angptl 3 / Angptl 4 negative(χ~2= 9. 376,7. 628;P = 0. 002,0. 006). Cox multivariate survival analysis showed that age, histological grade, tumor size, ER and PR status were independent risk factors in prognosis of invasive breast patients(OR = 6. 379,0. 033,66. 678,0. 014,0. 094;all P 0. 050;95% CI:1. 380- 29. 482,0. 002- 0. 598,5. 433- 818. 294,0. 001- 0. 183,0. 012- 0. 724),while Angptl 3 and Angptl 4 expressions were not(OR = 1. 262,1. 841;P = 0. 937,0. 695;95% CI:0. 000- 2. 281,0. 087-39. 051). Conclusions Angptl 3 and Angptl 4 are highly expressed in invasive breast cancer,with a positive correlation. The patients with Angptl 3 and Angptl 4 positive have a short survival,however the two are not the independent risk factors in the prognosis of invasive breast caner patients.
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2016年第2期76-81,共6页 Chinese Journal of Breast Disease(Electronic Edition)
关键词 乳腺肿瘤 血管生成素类 免疫组织化学 预后 Breast neoplasms Angiopoietins Immunohistochemistry Prognosis
  • 相关文献

参考文献21

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015, 65(1) :5-29.
  • 2Hato T, Tabata M, Oike Y. The role of angio.poietin-like proteins in angiogenesis and metabolism[ J 1- Trends Cardiovasc Med, 2008, 18 (1) :6-14.
  • 3Yu J, Kane S, Wu J, et al. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res, 2009, 15(9): 3023-3028.
  • 4Kim I, Kwak HI, Ahn JE, et al. Molecular cloning and characterization of a novel angiopeietin family protein, angiopoietin-3 [J]. FEBS Lett,1999, 443(3) :353-356.
  • 5KOster A, Chao YB, Mosior M, et al. Transgenic angiopoietin -like (angptl) 4 overexpression and targeted disruption of angptl 4 and angptl 3 : regulation of trigiycefide metabolism[ J ]. Endocrinology, 2005, 146 ( 11 ) : 4943.4950.
  • 6Kaplan R, Zhang T, Hernandez M, et al. Regulation of the angiopoietin-like protein 3 gene by LXR[J]. J Lipid Res, 2003, 44 (1) : 136-143.
  • 7Shimizugawa T, One M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein trigiyceride clearance by inhibition of lipeprotein lipase[J'l. J Biol Chem, 2002, 277(37) :33 742-33 748.
  • 8Shimamura M, Matsuda M, Yasumo H, et al. Angiopeietin-like protein 3 regulates plasma HDL cholesterol through suppression of endothelial lipase[J]. Arterioscler Thromb Vasc Biol, 2007, 27(2) :366-372.
  • 9One M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 ( ANGPTIB ) : ANGPTIB is cleaved and activated in vivo [ J 1- J Biol Chem, 2003, 278(43) :41 804-41 809.
  • 10宋其同,单云峰,周蒙滔,张启瑜,邹长林.血管生成素样蛋白3的表达及其与肝细胞癌侵袭和生长的关系研究[J].中华肝胆外科杂志,2006,12(7):450-452. 被引量:9

二级参考文献9

  • 1文卫,杨连粤,黄耿文,杨治力,刘合利,杨建青.TSP-1和VEGF在肝细胞癌新生血管生成中的作用[J].中华肝胆外科杂志,2005,11(1):17-19. 被引量:19
  • 2Koishi R.Angptl3 regulates lipid metabolism in mice.Nat Genet,2002,30:151-157.
  • 3Zhou X,Murphy FR,Gehdu N,et al.Engagement of αvβ3 integrin regulates proliferation and apoptosis of hepatic stellate cells.J Biol Chem,2004,279:23996-24006.
  • 4Vermeulen PB,Gasparini G,Fox SB,et al.Quantification of angiogenesis in solid human tumors:an international consensus on the methodology and criteria of evaluation.Eur J Cancer,1997,32A:2474-2484.
  • 5Folkman J.Angiogenesis in cancer,vascular,rheumatoid and other diseases.Nature Med,1995,1:27.
  • 6Konh E,Liotta L.Molecular insights into cancer invasion:strategies for prevention and intervention.Cancer Res,1995,55:1865.
  • 7Conklin D.Identification of a mammalian angiopoietin-related protein expressed specifically in liver.Genomics,1999,62:477-482.
  • 8Jones N,Iljin K,Dumont DJ,et al.Tie receptors:new modulators of angiogenic and lymphangiogenic responses.Nat Rev Mol Cell Biol,2001,2:257-267.
  • 9Camenisch G,Pisabarro M.ANGPTL3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo.J Boil Chem,2002,277:17281-17290.

共引文献8

同被引文献54

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部